NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD
2.84
+0.09 (+3.27%)
The current stock price of DH is 2.84 USD. In the past month the price increased by 13.37%. In the past year, price decreased by -59.6%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 35.78 | 38.48B | ||
DOCS | DOXIMITY INC-CLASS A | 46.35 | 11.13B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.04B | ||
CERT | CERTARA INC | 28.87 | 2.10B | ||
SDGR | SCHRODINGER INC | N/A | 1.85B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.18 | 1.80B | ||
PHR | PHREESIA INC | N/A | 1.51B | ||
EVH | EVOLENT HEALTH INC - A | 16.2 | 1.25B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.24B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
HSTM | HEALTHSTREAM INC | 51.62 | 1.04B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 781.29M |
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 782 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
DEFINITIVE HEALTHCARE CORP
492 Old Connecticut Path, Suite 401
Framingham MASSACHUSETTS US
CEO: Jason Krantz
Employees: 950
Company Website: https://ir.definitivehc.com/
Investor Relations: https://ir.definitivehc.com/
Phone: 15087204224
The current stock price of DH is 2.84 USD. The price increased by 3.27% in the last trading session.
The exchange symbol of DEFINITIVE HEALTHCARE CORP is DH and it is listed on the Nasdaq exchange.
DH stock is listed on the Nasdaq exchange.
22 analysts have analysed DH and the average price target is 4.64 USD. This implies a price increase of 63.42% is expected in the next year compared to the current price of 2.84. Check the DEFINITIVE HEALTHCARE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DEFINITIVE HEALTHCARE CORP (DH) has a market capitalization of 432.50M USD. This makes DH a Small Cap stock.
DEFINITIVE HEALTHCARE CORP (DH) currently has 950 employees.
DEFINITIVE HEALTHCARE CORP (DH) has a support level at 2.44 and a resistance level at 4.61. Check the full technical report for a detailed analysis of DH support and resistance levels.
The Revenue of DEFINITIVE HEALTHCARE CORP (DH) is expected to decline by -6.44% in the next year. Check the estimates tab for more information on the DH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DH does not pay a dividend.
DEFINITIVE HEALTHCARE CORP (DH) will report earnings on 2025-05-08, after the market close.
The PE ratio for DEFINITIVE HEALTHCARE CORP (DH) is 8.11. This is based on the reported non-GAAP earnings per share of 0.35 and the current share price of 2.84 USD. Check the full fundamental report for a full analysis of the valuation metrics for DH.
The outstanding short interest for DEFINITIVE HEALTHCARE CORP (DH) is 8.68% of its float. Check the ownership tab for more information on the DH short interest.
ChartMill assigns a technical rating of 1 / 10 to DH. When comparing the yearly performance of all stocks, DH is a bad performer in the overall market: 93.79% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to DH. The financial health of DH is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months DH reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS increased by 16.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -37.92% | ||
ROE | -92.97% | ||
Debt/Equity | 0.52 |
ChartMill assigns a Buy % Consensus number of 75% to DH. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -37.34% and a revenue growth -6.44% for DH